ABSTRACT -Nongonococcal urethritis is a venereal disease whose incidence is almost double that of gonorrhea. Despite this, the diagnosis, origin, treatment, and complications of nongonococcal urethritis remain unclear. Although some cases are undoubtedly caused by infection with Chlamydia trachomatis, the origin of many cases is uncertain. Treatment is recommended to shorten symptoms and prevent complications. This review presents the current status of this confusing disease.
Urethritis, or inflammation of the urethra, may be secondary to infection, trauma, allergy, foreign body, or an as yet undetermined
factor. An inlying urethral catheter is a well-recognized cause.
Likewise, infection with Neisseria gonorrhoeae often involves the urethra and is usually diagnosed and treated easily. The cause of most other cases of urethritis is more subtle, and in the past these cases have been grouped together as nonspecific urethritis.
The term nongonococcal urethritis applies to exactly the same entity, yet is more descriptive and, therefore, preferable.
The diagnosis is made only in men since the symptoms, and, therefore, the clinical characteristics of the disease are unknown in women.
Epidemiology
In England, where nongonococcal urethritis has been a reportable disease since 1951, there has been a documented tenfold increase in incidence from 1951 to 1978.'*2 By comparison, gonorrhea has increased slightly more than four times in incidence during the same period. Both gonococcal and nongonococcal urethritis are seen primarily between the ages of sixteen and twenty-six, and are much more common in single patients, as opposed to those married or divorced. 3 The incidence of nongonococcal urethritis is generally higher than that of gonococcal urethritis in students, whites, and upper middle-class populations. Following family studies of infants with inclusion conjunctivitis, the ophthalmologist, Lindner,' first connected C. trachomatis to nongonococcal urethritis in 1911. More recent studies have shown that C. trachomatis is isolated from the urethra in 30 to 40 per cent of patients with nongonococcal urethritis and only 5 to 10 per cent of controls.7-10 The question remains whether C. trachomatis is truly a pathogenic organism or merely part of the urethral flora. Bowie et al. l1 have performed serologic investigations which suggest C. trachomatis in the urethra is a significant infection. In their study, 100 per cent of 20 men with positive cultures for C. trachomatis were noted to have evidence of seroconversion; this is in contrast to 20 per cent of 39 men with negative cultures. Further evidence for the significance of the C. trachomatis is that therapy directed specifically against it will cure nongonococcal urethritis in 80 per cent of cases. Definitive proof of the role of C. trachomatis awaits fulfillment of Koch's postulates, including experimental urethral inoculations. This has been attempted on a small scale in baboons, but the results are inconclusive.12 In summary, C. trachomatis has not been proved to be an etiologic agent in nongonococcal urethritis; but the evidence is suggestive.
McCormack et al. l3 recently have presented an extensive review of the role of genital mycoplasmas in nongonococcal urethritis. They note eight controlled studies which support the role of T-mycoplasma in nongonococcal urethritis. They also note six equally valid controlled studies which show no association between T-mycoplasma and nongonococcal urethritis. In addition, they were unable to find any studies which document antibody against T-mycoplasma in large numbers of patients with nongonococcal urethritis. Artificial urethral inoculation has not been done, however evidence at this time is against a role for these organisms in nongonococcal urethritis.
T. vaginalis is rarely found in men, consequently the finding of this organism in 6 per cent of patients with nongonococcal urethritis is significant. lo Because of its low incidence, little research has been done on its role in nongonococcal urethritis.
While infection with C. trachomatis or T. vaginalis may cause nongonococcal urethritis in 40 to 50 per cent of cases, the others remain unexplained at this time. Scientific evidence supporting the role of trauma, allergy, or infection with a viral or fungal agent is lacking.
Treatment

Nongonococcal urethritis
Although most studies suggest a beneficial effect of tetracycline in nongonococcal urethritis i4pi5 there is some evidence to support the anecdotal impression that many cases resolve spontaneously. l6 All these studies, however, have serious methodologic shortcomings. Only in the study by Holmes, Johnson, and Floyd" could care be taken to insure that medication was taken as prescribed. Since it is thought that nongonococcal urethritis is not transmitted between homosexuals, and since this study was performed on an aircraft carrier at sea, sexual reexposure was not possible. Failure of therapy can then be assumed to be recurrence and not reinfection.
In this double-blind controlled study, successful treatment was achieved in 90 per cent of those treated for seven days, 65 per cent of those treated for four days, and 14 per cent of those treated with placebo. Most clinicians now accept that antibiotic therapy with tetracycline hydrochloride (1,500 mg. initially, then 500 mg. orally four times daily for seven days) will achieve clinical cure in 80 to 90 per cent of cases. Erythromycin or trimethoprimsulfamethoxazole can be used as alternative therapy. Penicillin, the treatment of choice for gonorrhea, is of no benefit in the treatment of nongonococcal urethritis.
Postgonococcal urethritis
After seemingly adequate treatment of gonococcal urethritis, 20 to 30 per cent of patients present with a clear mucoid discharge and mild dysuria, similar to nongonococcal urethritis. Urethral cultures of patients with gonorrhea reveal that C. trachomatis is present in 17 to 32 per cent of cases.7*g*10 Follow-up reveals that in 81 per cent of these patients postgonococcal urethritis will develop, as opposed to 10 per cent of those patients with gonorrhea who are negative for C. trachomatis.' Treatment with tetracycline will eradicate the postgonococcal urethritis in most cases.'O These data suggest a simultaneous infection with N. gonorrhoeae and the agent of nongonococcal urethritis. Holmes et al. l* suggest that in closely supervised or highly reliable patients, multiple 220 UROLOGY / MARCH 1981 / VOLUME XVII, NUMBER 3 doses of oral tetracycline may be the drug of choice for the treatment of gonorrhea. In most cases, though, gonorrhea should be treated with parenteral penicillin and postgonococcal urethritis should be treated as nongonococcal urethritis.
Recurrent nongonococcal urethritis
Those patients who repeatedly fail routine therapy for nongonococcal urethritis can be treated successfully.
A thorough systematic approach is necessary, taking into account compliance, reinfection, unusual organisms, and the possibility that the initial diagnosis is incorrect. It is well-known that milk products must be avoided when taking tetracycline, since calcium ions will bind the tetracycline, preventing absorption. The avoidance of milk products and a regimen of four doses per day, makes patient compliance difficult. Adherence to the treatment program should be stressed, as inadequate therapy will lead to recurrence.
The distinction between recurrence and reinfection is important. Bowie et al. l1 have shown that 64 per cent of cultures from the cervix of sexual partners of men with C. trachomatis on urethral culture, will also show C. trachomatis; this is in contrast to 5 per cent of controls. This justifies treating the patient and all sexual partners simultaneously, to prevent reinfection. In difficult cases, a search for other agents, e.g., T. vaginalis or Candida albicans, is occasionally rewarding. Since it is difficult to examine the urethral discharge, a check of the partner's cervical mucus for trichomonads or yeast is helpful.lg It has also been suggested that the trauma of repeated urethral "milking" may interfere with the host's ability to resolve the urethritis.lg Finally, the presence of a Cowper duct cyst or a urethral diverticulum can allow urinary accumulation and later "discharge" mimicking that of nongonococcal urethritis. This can be diagnosed easily on retrograde urethrogram.
There is the occasional patient with recurrent symptoms in whom no discharge is ever documented and no organic cause can be found. The diagnosis of psychogenic urethritis should be considered and appropriate therapy recommended.
Complications
In the past, nongonococcal urethritis has been considered a benign, selflimiting disease.20,21 Proof of its relationship with other diseases is difficult, since the cause of nongonococcal urethritis is itself uncertain. However, recent data indicate it may be involved in epididymitis, pelvic inflammatory disease, and infantile pneumonia.
Heap 22 first reported a relationship between acute epididymitis and C. trachomatis. A more extensive study by Berger et aZ.23 confirms that finding. The symptoms and signs of nongonococcal urethritis should be sought in all cases of epididymitis, and perhaps "sterile" epididymitis should be treated with antimicrobials, in particular, tetracycline.
Knowing the propensity for cervical colonization of female cohorts of patients with nongonococcal urethritis, there is a theoretical basis for finding disease caused by C. trachomatis in women and newborn infants. l1 Recently, Mkdh et aZ. 24 and Eilard et aZ.25 have isolated C. trachomatis from patients with acute salpingitis. Likewise, Beem and Saxon26 have associated C. trachomatis with a pneumonia syndrome in newborns. As mentioned previously, LindneP associated nongonococcal urethritis with inclusion conjunctivitis in the newborn in 1911.
Summary
Nongonococcal urethritis is characterized by slow onset of mild dysuria in a patient with a watery urethral discharge. Although a gram stain of the discharge generally reveals no organisms, the disease is thought to be infectious, with C. trachomatis being the etiologic agent in many cases. The occurrence of this disease after adequate treatment of gonorrhea is believed to represent simultaneous infection with N. gonorrhoeae and the etiologic agent for nongonococcal urethritis. Therapy with tetracycline is recommended for both nongonococcal and postgonococcal urethritis to alleviate symptoms and avoid complications.
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